Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - amlodipinum, valsartanum, hydrochlorothiazidum - comprimés pelliculés - filmtablette: amlodipinum 5 mg ut amlodipini besilas 6.944 mg, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, e 171, e 172 (flavum), pro compresso obducto. - essentielle hypertonie - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - amlodipinum, valsartanum, hydrochlorothiazidum - comprimés pelliculés - filmtablette: amlodipinum 10 mg ut amlodipini besilas 13.888 mg, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, e 171, e 172 (flavum), pro compresso obducto. - essentielle hypertonie - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - clozapinum - comprimés - clozapinum 25.000 mg, lactosum monohydricum 48.000 mg, maydis amylum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, talcum, pro compresso. - neurolepticum - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - clozapinum - comprimés - clozapinum 100 mg, lactosum monohydricum 192 mg, maydis amylum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, talcum, pro compresso. - neurolepticum - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - fingolimodum - gélules - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, calcii hydrogenophosphas dihydricus, glycinum, silica colloidalis anhydrica, magnesii stearas, kapselhülle: e 171, gelatina, e 172 (rubrum), e 172 (flavum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula. - multiple sklerose - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - exemestanum - comprimés pelliculés - exemestanum 25 mg, mannitolum, hypromellosum, crospovidonum, polysorbatum 80, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, silica colloidalis anhydrica, Überzug: carmellosum natricum, maltodextrinum, glucosum monohydricum 0.441 mg, acidum stearicum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.15 - 0.25 mg. - 2ème et 3ème ligne de traitement du carcinome mammaire-ca, post-ménopausique chez les patientes - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - emtricitabinum, tenofovirum disoproxilum - comprimés pelliculés - emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili maleas 300 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, lactosum monohydricum 82.79 mg, magnesii stearas, e 172 (rubrum), Überzug: lactosum monohydricum 10.78 mg, hypromellosum, triacetinum, e 133, e 171, e 172 (flavum), pro compresso obducto. - l'infection à vih - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - etoricoxibum - comprimés pelliculés - etoricoxibum 30 mg, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, hypromellosum, lactosum monohydricum 0.84 mg, e 171, triacetinum, cera carnauba, e 133, e 172 (nigrum), e 172 (flavum), pro compresso obducto corresp. natrium 0.45 mg. - sélectif de la cox-2 inhibiteurs de la - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - etoricoxibum - comprimés pelliculés - etoricoxibum 60 mg, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, hypromellosum, lactosum monohydricum 1.68 mg, e 171, triacetinum, cera carnauba, e 172 (flavum), e 132, pro compresso obducto corresp. natrium 0.9 mg. - sélectif de la cox-2 inhibiteurs de la - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - letrozolum - comprimés pelliculés - letrozolum 2.5 mg, lactosum monohydricum 61.5 mg, cellulosum microcristallinum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.14-0.21 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (flavum) pro compresso obducto. - cytostatikum - synthetika